Clinical Trials Browser

Interventional × Adenocarcinoma × PEGPH20 × Clear all

NCT02487277 2020-01-02

PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma

Phase 2 Terminated

3 enrolled 8 charts

Adenocarcinoma

NCT03634332 2019-05-07

Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms